Monocytic skin nodules in chronic myelomonocytic leukemia: Clinical response to decitabine therapy [1]

Leukemia and Lymphoma

Volumn 48, Issue 8, 2007, Pages 1628-1629

  Steensma, David P ^a   Friday, Bret B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; BORTEZOMIB;

AGED; BONE MARROW EXAMINATION; CASE REPORT; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DEATH; DRUG WITHDRAWAL; FEMALE; FUNGEMIA; HUMAN; LETTER; MONOCYTE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SINGLE DRUG DOSE; SKIN BIOPSY; SKIN NODULE; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; DNA MODIFICATION METHYLASES; FEMALE; HUMANS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MONOCYTES; SKIN DISEASES;

EID: 34547983832     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701435267     Document Type: Letter

References (6)

1. Cortes, J. (2003) CMML: A biologically distinct myeloproliferative disease. Curr Hematol Rep, 2, pp. 202-208.
2. McCollum, A., Bigelow, C. L., Elkins, S. L., Hardy, C. L. and Files, J. C. (2003) Unusual skin lesions in chronic myelomonocytic leukemia. South Med J, 96, pp. 681-684.
3. Doutre, M. S., Beylot, C., Bioulac, P. and de Mascarel, A. (1990) Skin presentation of chronic myelomonocytic leukaemia resembling cutaneous lymphomas. J R Soc Med, 83, pp. 593-594.
4. Wattel, E., Guerci, A., Hecquet, B., Economopoulos, T., Copplestone, A. and Mahe, B. (1996) A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Francais des Myelodysplasies and European CMML Group. Blood, 88, pp. 2480-2487.
5. Kantarjian, H., Oki, Y., Garcia-Manero, G., Huang, X., O'Brien, S. and Cortes, J. (2007) Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood, 109, pp. 52-57.
6. Aribi, A., Borthakur, G., Ravandi, F., Shan, J., Davisson, J. and Cortes, J. (2007) Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia. Cancer, 109, pp. 713-717.